Market LIVE
Published markets; coverage varies by country
Product profile · United States

RYALTRIS

 ·  Patent Litigation & Settlement History ↓

IngredientMOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
Application typeNDA
Application211746
Product001
Dosage formSPRAY, METERED
RouteNASAL
Strength0.025MG/SPRAY;0.665MG/SPRAY
Approval date2022-01-13
Marketing statusPrescription
Status event—
ApplicantGLENMARK SPECLT
Product source

Current GenericRadar decision

Year2025
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeREGULATORY_EXCLUSIVITY
Anchor date2025-01-13
Patent anchor—
Exclusivity anchor2025-01-13
Protection date2044-11-21
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2025. Anchor type: REGULATORY_EXCLUSIVITY. Patent anchor: not recorded. Exclusivity anchor: 2025-01-13. Anchor date: 2025-01-13. Patent tail: yes. Exclusivity tail: yes. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
100164432034-09-04U U-3297NNU
English description not available.
———
100164432034-09-04ORANGE_BOOK U-3297NNU
English description not available.
———
103765262034-09-04DP —NNDP
English description not available.
———
103765262034-09-04ORANGE_BOOK —NNDP
English description not available.
———
105178802034-09-04DP/U U-3297NNDP
English description not available.
———
105178802034-09-04ORANGE_BOOK U-3297NNDP
English description not available.
———
105489072034-09-04U U-3297NNU
English description not available.
———
105489072034-09-04ORANGE_BOOK U-3297NNU
English description not available.
———
105616722034-09-04DP —NNDP
English description not available.
———
105616722034-09-04ORANGE_BOOK —NNDP
English description not available.
———
106465002034-09-04U U-3297NNU
English description not available.
———
106465002034-09-04ORANGE_BOOK U-3297NNU
English description not available.
———
107585502034-09-04U U-3296NNU
English description not available.
———
107585502034-09-04ORANGE_BOOK U-3296NNU
English description not available.
———
107656862034-09-04U U-3295NNU
English description not available.
———
107656862034-09-04ORANGE_BOOK U-3295NNU
English description not available.
———
114001012034-09-04U U-3297NNU
English description not available.
———
114001012034-09-04ORANGE_BOOK U-3297NNU
English description not available.
———
120644422034-09-04U U-3297NNU
English description not available.
———
120644422034-09-04ORANGE_BOOK U-3297NNU
English description not available.
———
90789232034-09-04DP/U U-3297NNDP
English description not available.
———
90789232034-09-04ORANGE_BOOK U-3297NNDP
English description not available.
———
93704832034-09-04DP —NNDP
English description not available.
———
93704832034-09-04ORANGE_BOOK —NNDP
English description not available.
———
97507542034-09-04DP/U U-3297NNU
English description not available.
———
97507542034-09-04ORANGE_BOOK U-3297NNU
English description not available.
———
99371892034-09-04DP —NNDP
English description not available.
———
99371892034-09-04ORANGE_BOOK —NNDP
English description not available.
———
116792102038-09-03DP —NNDP
English description not available.
———
116792102038-09-03ORANGE_BOOK —NNDP
English description not available.
———
123036352039-04-08DS/DP —NNDP
English description not available.
———
123036352039-04-08ORANGE_BOOK —NNDP
English description not available.
———
126538332044-11-21DP/U U-4564NNDP
English description not available.
———
126538332044-11-21ORANGE_BOOK U-4564NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2022-01-132025-01-13English description not available.YY2025-01-13
NP
Full coverage date: 2025-01-13
Source
NPP2026-07-072029-07-07English description not available.NN——Source
NPP2026-07-072029-07-07English description not available.NN—
NP
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (20)
TypeDateRoleBasisSource
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2034-09-04FTO_TAILEnglish description not available.Source
PATENT2038-09-03FTO_TAILEnglish description not available.Source
PATENT2039-04-08FTO_TAILEnglish description not available.Source
PATENT2044-11-21FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_EXCLUSIVITY—FTO_TAILEnglish description not available.Source
REGULATORY_STATUS2025-01-13CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.